• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝门部胆管癌——病例报告]

[Klatskin tumor - a case report].

作者信息

Iwaniec-Karlikowska Edyta, Augustyn Monika, Grys Iwon

机构信息

Department of Internal Medicine and Gastroenterology, 5th Military Hospital in Cracow, Poland.

出版信息

Pol Merkur Lekarski. 2016 Feb;40(236):107-9.

PMID:27000815
Abstract

UNLABELLED

Cholangiocarcinoma (CCA) is the second most frequent liver malignancy, responsible for 10-15% primary liver cancers. This tumor is difficult to diagnose and characterized by high mortality rate. Extrahepatic CCA is a specific type known as Klatskin tumor.

A CASE REPORT

The patient was admitted to the Clinic of Internal Medicine and Gastroenterology with intrahepatic cholestasis. Imaging revealed Bismuth type IV hilum tumor. Due to rare occurrence of this malignancy the patient was directed to the tertiary center. During surgical exploration radical treatment was abandoned as a result of tumor's advanced stadium. Histology evaluation revealed infiltrating adenocarcinoma. ERCP and biliary duct stenting was performed. The patient was qualified for paliative chemotherapy according to gemcytabine+cisplatine protocol (d1, d15 every 28 days). Posttreatment follow-up revealed total remission of the tumor.

摘要

未标注

胆管癌(CCA)是第二常见的肝脏恶性肿瘤,占原发性肝癌的10 - 15%。这种肿瘤难以诊断,死亡率高。肝外CCA是一种特殊类型,称为Klatskin瘤。

病例报告

患者因肝内胆汁淤积入住内科和胃肠病学诊所。影像学检查显示为IV型肝门部肿瘤。由于这种恶性肿瘤罕见,患者被转诊至三级中心。手术探查时,由于肿瘤处于晚期,放弃了根治性治疗。组织学评估显示为浸润性腺癌。进行了内镜逆行胰胆管造影(ERCP)和胆管支架置入术。患者按照吉西他滨+顺铂方案(每28天的第1天和第15天)接受姑息化疗。治疗后随访显示肿瘤完全缓解。

相似文献

1
[Klatskin tumor - a case report].[肝门部胆管癌——病例报告]
Pol Merkur Lekarski. 2016 Feb;40(236):107-9.
2
Perihilar clear cell cholangiocarcinoma: an often-diagnostic challenge.肝门部透明细胞胆管细胞癌:一个常见的诊断难题。
BMJ Case Rep. 2020 Dec 22;13(12):e237683. doi: 10.1136/bcr-2020-237683.
3
[Successful R0 Resection of Hilar Cholangiocarcinoma by Extrahepatic Bile Duct Resection Due to Accompanying Liver Dysfunction after Neoadjuvant Gemcitabine/Cisplatin/S-1 Combination Chemotherapy-A Case Report].[新辅助吉西他滨/顺铂/S-1 联合化疗后因肝功能障碍行肝外胆管切除成功 R0 切除肝门部胆管癌——病例报告]
Gan To Kagaku Ryoho. 2019 Feb;46(2):342-344.
4
Current Management of Perihilar Cholangiocarcinoma and Future Perspectives.肝门部胆管癌的当前管理及未来展望
Chirurgia (Bucur). 2017 May-Jun;112(3):193-207. doi: 10.21614/chirurgia.112.3.193.
5
Consensus conference on hilar cholangiocarcinoma.肝门部胆管癌共识会议
HPB (Oxford). 2015 Aug;17(8):666-8. doi: 10.1111/hpb.12451.
6
Cholangiocellular Carcinoma.胆管细胞癌
Digestion. 2017;95(3):181-185. doi: 10.1159/000454763. Epub 2017 Mar 14.
7
Clinical treatment of cholangiocarcinoma: an updated comprehensive review.胆管癌的临床治疗:最新综合综述。
Ann Hepatol. 2022 Sep-Oct;27(5):100737. doi: 10.1016/j.aohep.2022.100737. Epub 2022 Jul 7.
8
Placement of ¹²⁵I seed strands and stents for a type IV Klatskin tumor.¹²⁵I 粒子条及支架置入治疗IV型肝门部胆管癌
World J Gastroenterol. 2015 Jan 7;21(1):373-6. doi: 10.3748/wjg.v21.i1.373.
9
Klatskin tumor diagnosed concurrently with IgG4 related sclerosing cholangitis: A case report.同时诊断为克氏壶腹周围癌与IgG4相关性硬化性胆管炎:一例报告。
Medicine (Baltimore). 2020 Aug 21;99(34):e21936. doi: 10.1097/MD.0000000000021936.
10
Comment on "Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma".关于“辅助性S-1与吉西他滨治疗淋巴结阳性肝门部胆管癌的比较”的评论
J Hepatobiliary Pancreat Sci. 2022 Apr;29(4):e28. doi: 10.1002/jhbp.1072. Epub 2021 Nov 8.